Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Poster Presentations

Pituitary, Neuroendocrinology and Puberty P2

Efficacy and Safety of Triptorelin 3-Month Formulationin Patients with Central Precocious Puberty and BMI Evaluation.
University of Verona; Unit of Pediatrics, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Verona, Italy
hrp0089p2-p301
Triptorelin Test in Idagnosing Central Precocious Puberty
aMother and Child Healthcare Institute of Serbia, Belgrade, Serbia; bSchool of Medicine, University of Belgrade, Belgrade, Serbia
hrp0089p2-p302
Foot Length Growth is a Novel Marker of Early Puberty
aUniversity of Sydney, Sydney, Australia; bThe Children’s Hospital at Westmead, Sydney, Australia; cUniversity of New South Wales, Sydney, Australia; dIngham Institute of Applied Medical Research, Liverpool, Australia; eANZAC Research Institute, Sydney, Australia
hrp0089p2-p303
Ultrasound-Based Measurements of Testicular Volume in 6-16 Year Old Boys: Intra- and Inter-Observer Agreement and Comparison with Prader Orchidometry
aDepartment of Clinical Science, University of Bergen, Bergen, Norway; bDepartment of Pediatrics, Haukeland University Hospital, Bergen, Norway; cEnvironment and Health, Department of Public Health and Primary Care, KU Leuven – University of Leuven, Leuven, Belgium; dCentre for Clinical Resarch, Haukeland University Hospital, Bergen, Norway; eDepartment for Global Public Health and Primary Care, University of Bergen, Bergen, Norway; fDepartment of Radiology, Haukeland University Hospital, Bergen, Norway; gDepartment of Clinical Medicine, University of Bergen, Bergen, Norway
hrp0089p2-p304
Abstract unavailable
hrp0089p2-p305
Longitudinal Follow-up to Near Final Height of Auxological Changes in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analog and Grouped by Pretreatment BMI level
aDepartmenmt of Pediatrics, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea; bDepartment of Preventive Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea
hrp0089p2-p306
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and Their Families
aDepartment of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; bPost-graduate School of Paediatrics, University of Modena and Reggio Emilia, Modena, Italy; cPaediatric Unit, University Hospital of Modena, Modena, Italy
hrp0089p2-p307
MKRN3 Gene Mutations in a Cohort of Patients with Central Precocious Puberty
aUniversity Children’s Hospital Ljubljana, Ljubljana, Slovenia; bFelsentein Medical Research Center, Petah Tikva, Israel; cThe Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel; dSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; eUniversity Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina; fUniversity Hospital Centre Sestre Milosrdnice, Zagreb, Croatia; gInstitute for Health Protection of Mother and Child of Serbia, Beograd, Serbia; hUniversity Children’s Hospital Skopje, Skopje, Republic of Macedonia, The Former Yugoslav; iUniversity Children‘s Hospital Tiršova, Beograd, Serbia; jClinic for Childrens Internal Disease, Clinical Center Niš, Niš, Serbia; kFaculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
hrp0089p2-p309
Incidence of Delayed Puberty in Adolescents. A Population-Based Study in a County in Central Sweden
aDepartment of Pediatrics, Örebro University Hospital, Örebro, Sweden; bSchool of Medical Sciences, Örebro University, Örebro, Sweden; cDepartment of Endocrinology, Örebro University Hospital, Örebro, Sweden
hrp0089p2-p311
Ultrasound Assessment of Pubertal Breast Development: Intra- and Inter-Observer Agreement
aUniversity of Bergen, Bergen, Norway; bHaukeland University Hospital, Bergen, Norway; bUniversity of Leuven, KU Leuven, Belgium
hrp0089p2-p312
Neuroendocrine Consequences of Hypothalamic Hamartoma and their Imaging (MRI) and Surgery Correlates
aEndocrinology, Great Ormond Street Hospital for Children, London, UK; bNeuroimaging, Great Ormond Street Hospital for Children, London, UK; cNeurosurgery, Great Ormond Street Hospital for Children, London, UK; dNeurology, Great Ormond Street Hospital for Children, London, UK
hrp0089p2-p313
The Start Predictors of Puberty in Boys with Constitutional Delay of Puberty
Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
hrp0089p2-p314
Research on the Relationship between Secular Trends of Pubertal Development and Obesity in Child and Adolescent
Children’s Hospital of Chongqing Medical University, Chongqing, China
hrp0089p2-p315
The Effect of Letrozole on the Reproductive Function and Linear Growth in the Early and Mid Puberty Boys
aThe First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; bThe third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
hrp0089p2-p317
SOX3 Gene Duplication Associated with Midline CNS Malformations, Hypopituitarism and Neurodevelopmental Abnormalities: 5 Unrelated Cases
aKing’s College Hospital NHS Foundation Trust, London, UK; bNorth Middlesex Hospital NHS Trust, London, UK; cEast Sussex Healthcare NHS Trust, Eastbourne, UK; dWestern Sussex Hospital NHS Trust, Worthing, UK; eGuys and St Thomas Hospitals NHS Trust, London, UK
hrp0089p2-p318
An 18 Month Old Boy with Hypoglycemic Convulsion and Obesity Due to POMC Deficiency
aMarmara University Faculty of Medicine, Department of Pediatric Endocrinology, Istanbul, Turkey; bDepartment of Medical Genetics, Bezmialem Vakıf University School of Medicine, Istanbul, Turkey
hrp0089p2-p319
Pituitary Stalk Interruption Syndrome (PSIS) is Not a Rare Cause of the Congenital Hypopituitarism
aUludag University, Faculty of Medicine, Department od Pediatric Endocrinology, Bursa, Turkey; bUludag University, Faculty of Medicine, Department of Pediatric Radiology, Bursa, Turkey
hrp0089p2-p320
Primary Empty Sella Syndrome and Clnical Endocrine Polymorphisms in Children: a Report of 15 Cases
aCentre Hospitalier du Valais Romand, Sion, Switzerland; bDevelopmental Endocrinology Research Group, University College, London, UK; cUniversity Teaching Hospital, Montpellier, France
hrp0089p2-p322
Endocrine-Metabolic Characterization of Pediatric Patients with Craniopharyngioma: A Single-centre Cohort study
aUnit of Endocrinology, ‘Bambino Gesù’ Children’s Hospital, IRCCS, Rome, Italy; bDepartment of Systems Medicine, University of Rome ‘Tor Vergata’, Rome, Italy; cDiabetology Unit, ‘Bambino Gesù’ Children’s Hospital, IRCCS, Rome, Italy; dDepartment of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
hrp0089p2-p324
Growth Hormone (GH) Secreting Pituitary Adenomas in Paediatric Practice: 5 Cases Over 20 Years in a Single Tertiary NeuroEndocrine Centre
aKing’s College Hospital NHS Foundation Trust, London, UK; bRoyal Alexandra Childrens Hospital, Brighton, UK; cRoyal Marsden NHS Foundation Trust, London, UK
hrp0089p2-p325
Pituitary Adenomas in Children and Adolescents: A Retrospective Single-Centre Analysis
aDivision of Paediatric Endocrinology and Diabetes, Department of Paediatrics, University Hospital Heidelberg, Heidelberg, Germany; bNeuroradiology, University Hospital Heidelberg, Heidelberg, Germany; cMolecular Laboratory, Prof. F. Raue, Heidelberg, Germany
hrp0089p2-p326
AMH and Inhibin B Level in Girls with Central Precocious Puberty
aDepartement of Pediatrics, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea; bDepartement of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University, College of Medicine, Seoul, Republic of Korea; cDepartement of Pediatrics, Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea
hrp0089p2-p328
Gender-Related Differences in Etiological Distribution of Organic Causes of Central Precocious Puberty
aHacettepe University Medica, Ankara, Turkey; bHacettepe University Medical School, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey
hrp0089p2-p329
The Impact of Central Precious Puberty on Health-relatedqualityoflifeand Social, Emotive and Behavioral Competences Among Children Treated with GnRHa
University of Verona; Unit of Pediatrics, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Verona, Italy
hrp0089p2-p331
Hypertension During GNRH Analogues Therapy in a 10-year-old Girl
aASP Cosenza, cetraro, Italy; bMagna Graecia University, Catanzaro, Italy
hrp0089p2-p334
The Effect of Polychlorinobiphenyls on Premature Puberty in Girls
aEge University School Of Medicine, Department of Pediatrics, İzmir, Turkey; bEge University School of Medicine, Deparment of Pediatric Endocrinology, İzmir, Turkey
hrp0089p2-p335
A Novel Mutation in 5'; Untranslation Region of Makorin Ring Finger 3 Gene Associated with the Familial Precocious Puberty
aDepartment of Pediatric, Ruijin Hospital Affiliated with Shanghai Jiao Tong University, Shanghai, China; bState Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network; Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China
hrp0089p2-p336
A Case of Testotoxicosis Due to a Constitutive Mutation of the LH Receptor Initially Presented as a Central Precocious Puberty at 3 Years Old
aToulouse Hospital, Toulouse, France; bRobert Debré Hospital, Paris, France; cParis Diderot University, Paris, France
hrp0089p2-p337